MENU

VRDN Viridian Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VRDN is expected to report earnings to -100 cents per share on November 11

Viridian Therapeutics VRDN Stock Earnings Reports
Q3'24
Est.
$-1.01
Q2'24
Missed
by $0.15
Q1'24
Beat
by $0.30
Q4'23
Missed
by $0.37
Q3'23
Beat
by $0.16
The last earnings report on August 08 showed earnings per share of -101 cents, missing the estimate of -87 cents. With 1.14M shares outstanding, the current market capitalization sits at 900.21M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RBRCX15.87N/A
N/A
RBC Small Cap Core R6
PCIEX19.02-0.01
-0.05%
PACE International Equity P
EPGCX15.33-0.02
-0.13%
Fidelity Advisor Equity Growth C
GEACX20.08-0.07
-0.35%
GMO Resources I
HGXSX15.59-0.06
-0.38%
Hartford Global Impact R4

VRDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-9.10%
ALLO - VRDN
51%
Loosely correlated
-2.71%
NTLA - VRDN
49%
Loosely correlated
-1.55%
FATE - VRDN
49%
Loosely correlated
+0.85%
VIR - VRDN
48%
Loosely correlated
+0.72%
ABCL - VRDN
47%
Loosely correlated
-3.57%
More